Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST 2)

This study has been completed.
Information provided by:
Pfizer Identifier:
First received: February 28, 2007
Last updated: October 24, 2007
Last verified: April 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2004
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):